EKEvan H. Kirkpatrick

Evan H. Kirkpatrick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Evan H. Kirkpatrick has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Atomistic TCR-ligand interactions shape memory T-cell differentiation

    by Aoi Akitsu, Kemin Tan, Robert J Mallis, Matthew A Booker, Jonathan S Duke-Cohan, Kristine N Brazin, Evan H Kirkpatrick, Andrew N Parkins, Sarita Aryal, Vincenzo Cinella, et al.

    Summary: Memory CD8⁺ T cells provide durable protection against recurrent infection and cancer, but how distinct memory fates are specified remains unclear. Here, we define the functional landscape of 242 murine CD8⁺ TCRαβ clonotypes specific for influenza NP 366–374 /H-2Dᵇ ligand (pMHC) by integrating single-cell transcriptomics and TCR sequencing with force-dependent biophysics, structural analysis, and in vivo investigation of memory development. Fate essentially tracks with TCR mechanotransduction: T CM -associated clonotypes preferentially engage pMHC through TCRβ, whereas T EM -associated clonotypes preferentially engage through TCRα. Clonotypes with balanced, bipolar signaling generate both memory subsets, optimize expansion, and display broad heterosubtypic crossreactivity but with exhaustion susceptibility. In contrast, diverse T CM clonotypes are largely clonal singlets with considerable mutant-epitope recognition in aggregate and stemness preservation, revealing complementary strategies for immunodefense coverage. Atomistically, subtle pMHC contact differences and load transmission through the TCR holoreceptor appear to tune phosphorylation, memory differentiation, and functional durability, features applicable to adoptive T-cell immunotherapies.

  • Open Access

    Parsing digital or analog TCR performance through piconewton forces

    by Aoi Akitsu, Eiji Kobayashi, Yinnian Feng, Hannah M. Stephens, Kristine N. Brazin, Daniel J. Masi, Evan H. Kirkpatrick, Robert J. Mallis, Jonathan S. Duke-Cohan, Matthew A. Booker, et al.

    αβ T cell receptors (TCRs) principally recognize aberrant peptides bound to major histocompatibility complex molecules (pMHCs) on unhealthy cells, amplifying specificity and sensitivity through physical load placed on the TCR-pMHC bond during immunosurveillance. To understand this mechanobiology, TCRs stimulated by abundantly and sparsely arrayed epitopes (NP 366–374 /D b and PA 224–233 /D b , respectively) following in vivo influenza A virus infection were studied with optical tweezers. While certain NP repertoire CD8 T lymphocytes require many ligands for activation, others are digital, needing just few. Conversely, all PA TCRs perform digitally, exhibiting pronounced bond lifetime increases through sustained, energizing volleys of structural transitioning. Optimal digital performance is superior in vivo, correlating with ERK phosphorylation, CD3 loss, and activation marker up-regulation in vitro. Given neoantigen array paucity, digital TCRs are likely critical for immunotherapies.